FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / DELIVERY ORDER

THE PURPOSE OF THIS PROJECT IS TO PROVIDE CLINICAL SUPPORT FOR INFANTILE GM1 GENE THERAPY CLINICAL TRIAL

Awarded to MEDICAL SCIENCE & COMPUTING, LLC

PIID 75N98021F00049US · USAspendingOther
$229.7K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$229,739sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJun 25, 2021
Company legal name
MEDICAL SCIENCE & COMPUTING, LLC
UEI / CAGE
QKC5FQ63F7Z4 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Other
NAICS
541990
PSC
R499
Performance period
Not reported — Not reported
Recipient address
11300 ROCKVILLE PIKE STE 1100, ROCKVILLE, MONTGOMERY, MD, 20852
Place of performance
ROCKVILLE, MONTGOMERY, MD, 20850
Source last modified
Nov 3, 2026

Description

THE PURPOSE OF THIS PROJECT IS TO PROVIDE CLINICAL SUPPORT FOR INFANTILE GM1 GENE THERAPY CLINICAL TRIAL

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    THE PURPOSE OF THIS PROJECT IS TO PROVIDE CLINICAL SUPPORT FOR INFANTILE GM1 GENE THERAPY CLINICAL TRIAL

    US · usaspendingSource ↗
  2. Value increased

    THE PURPOSE OF THIS PROJECT IS TO PROVIDE CLINICAL SUPPORT FOR INFANTILE GM1 GENE THERAPY CLINICAL TRIAL

    US · usaspending$229.7KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jun 25, 20210Not reported$229,738.50Not reportedNot reportedTHE PURPOSE OF THIS PROJECT IS TO PROVIDE CLINICAL SUPPORT FOR INFANTILE GM1 GENE THERAPY CLINICAL TRIALUSAspending ↗